Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Reexamination Certificate
2005-09-20
2005-09-20
Peselev, Elli (Department: 1623)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
C536S007300, C536S007400
Reexamination Certificate
active
06946446
ABSTRACT:
The invention relates to novel methods for using macrolide anti-infective agents. The macrolide anti-infective agents demonstrate antibacterial activity against multi-drug resistant strains of bacteria and, in particular, methicillin-resistantStaphylococcus aureus(MRSA). Methods for inhibiting the activity of multi-drug resistant bacterial organisms and methods for treating a bacterial infection caused by such organisms are described herein.
REFERENCES:
patent: 4331803 (1982-05-01), Watanabe et al.
patent: 4670549 (1987-06-01), Morimoto et al.
patent: 4680368 (1987-07-01), Nakamoto et al.
patent: 4990602 (1991-02-01), Morimoto et al.
patent: 5523399 (1996-06-01), Asaka et al.
patent: 5631355 (1997-05-01), Asaka et al.
patent: 5770579 (1998-06-01), Agouridas et al.
patent: 5866549 (1999-02-01), Or et al.
patent: 6075011 (2000-06-01), Or et al.
patent: 0194833 (1986-09-01), None
patent: 0260938 (1988-03-01), None
patent: 0487411 (1992-05-01), None
patent: 0680967 (1995-11-01), None
patent: 1167375 (2002-01-01), None
patent: 2732023 (1996-09-01), None
patent: 2732032 (1996-09-01), None
patent: 9742204 (1997-11-01), None
patent: 9856800 (1998-12-01), None
patent: WO 98/56800 (1998-12-01), None
patent: 0061593 (1999-10-01), None
Schempp et al, “Antibacterial activity of hyperforin from St John's wort, against multiresistantStaphylococcus aureusand gram-positive bacteria”, 353, No. 9170 (1999), p. 2129.
Agouridas et al, “Synthesis and antibacterial activity of Ketolides (6-0-Methyl-3-Oxoerythromycin Derivatives): A New Class of Antibaterials Highly Potent Against Macrolide-Resistant and Susceptible Respiratory Pathyogens”, Journal of Medicinal Chemistry, American Chemical Society, 21 (41), 4080-4100 (1998).
Bertho, et al., “Solution conformation of methylated macrolide antibiotics roxithromycin and erythromycin using NMR and molecular modeling. Ribosome-bound conformation determined by TRNOE and formulation of cytochrome P450-metabolite complex”, International Journal of Biological Macromolecules (1998), 22(2), 103-127.
Derwent Publications Ltd, London, XP002219408, “New erythromycin derivatives are antimicrobial agents active e.g. Mycobacterium avium complex”.
Y. Kawashima et al.,Structure-Activity Relationship Study of 6-O-Methylerythromycin 9-O Substituted oxime Derivatives, Chem. Pharm. Bull., 42(5):1088-1095 (1994).
J.J. Schentag, et al., “Genesis of Methicillin-ResistantStaphylococcus aureus(MRSA). How Treatment of MRSA Infections Has Selected for Vancomycin- ResistantEnterococcus faecium, and the Importance of Antibiotic Management and Infection Control”, Clinical Infectious Diseases, 26; 1204-14 (1998).
F. Baquero, et al., “Gram-positive resistance: challenge for the development of new antibiotics”, Journal of Antimicrobial Chemotherapy, 39; Suppl. A, 1-6 (1997).
Y. Kawashima et al., “Structure-Activity Relationship Study of 6-O-Methylerythromycin 9-O-Substituted Oxime Derivatives”, Chem. Pharm. Bull, vol. 42 No. 5, pp.1088-1095 (1994).
Ma Zhenkun
Nemoto Peter
Or Yat Sun
Yong Hong
Zhang Suoming
Abbott Laboratories
Donner B. Coregory
Peselev Elli
LandOfFree
Anti-infective agents useful against multidrug-resistant... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Anti-infective agents useful against multidrug-resistant..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Anti-infective agents useful against multidrug-resistant... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3391555